The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 17267215 |
27 |
Oxazolidinones as novel human CCR8 antagonists. |
Glaxosmithkline |
| 19954248 |
85 |
Increasing selectivity of CC chemokine receptor 8 antagonists by engineering nondesolvation related interactions with the intended and off-target binding sites. |
Astrazeneca |
| 18257512 |
33 |
Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships. |
Astrazeneca |
| 22957890 |
174 |
Modulation in selectivity and allosteric properties of small-molecule ligands for CC-chemokine receptors. |
University Of Copenhagen |
| 17266208 |
104 |
Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8. |
Millennium Pharmaceuticals |
| 16698264 |
37 |
Discovery of 3,5-bis(trifluoromethyl)benzyl L-arylglycinamide based potent CCR2 antagonists. |
Merck Research Laboratories |
| 16640325 |
41 |
Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8). |
Millennium Pharmaceuticals |
Search and Browse
